Among them, one cDC type 1, expressing CLEC9A and CADM1, four subpopulations of cDC type 2, three of them DC2, distinguished by CD1C expression, and one DC3, one DC4, one mature subpopulation expressing LAMP3 and CCR7 and a poorly described phenotype, DC_CXCL8, that exhibits contrasting prognostic implications in different tumor types. This evidence concerns the gene CXCL8 and neoplasm.